Navigation Links
Wedgewood Pharmacy: U.S. Court of Appeals Vacates DEA Action
Date:12/12/2007

SWEDESBORO, N.J., Dec. 12 /PRNewswire/ -- Yesterday, the U.S. Court of Appeals for the District of Columbia Circuit vacated the Drug Enforcement Administration's (DEA) 2006 revocation of Wedgewood Pharmacy's registration to dispense controlled substances. Wedgewood has been challenging the DEA's decision since it first was issued.

The ruling consolidated two petitions: the company's appeal of the DEA's decision and the DEA's denial of Wedgewood's petition for reconsideration. The court explained that it does not set-aside Federal agency rulings "unless the interpretation is arbitrary, capricious, or manifestly contrary to the statute ... [and] if the agency ... entirely failed to consider an important aspect of the problem, offered an explanation for its decision that runs counter to the evidence before the agency, or is so implausible that it could not be ascribed to a difference in view or the product of agency expertise." The unanimous ruling, authored by Circuit Judge Karen LeCraft Henderson, noted "we cannot help but conclude that the DA's [DEA's Deputy Administrator] decision 'entirely failed to consider an important aspect of the problem,'" that is, "whether animal medicine operates differently from human medicine."

George J. Malmberg, R.Ph., F.A.C.A, F.A.C.V.P., the pharmacist president and CEO of Wedgewood Pharmacy, noted: "The Court made clear its concern that the practice of veterinary medicine differs from the practice of human medicine. We believe that the current standard of practice in our profession, which is to dispense controlled substances to veterinarians rather than to horse owners or stable personnel, is consistent with the law's intention to prevent the improper use of controlled substances. We look forward to having our registration restored by the DEA, though the timing of that will depend upon the agency's response to this ruling."

The DEA objected to Wedgewood's practice of preparing compounded controlled-substa
'/>"/>

SOURCE Wedgewood Pharmacy
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement
2. Texas Supreme Court Rules Against Medicare HMOs in Hospital Reimbursement Fight
3. Claim Filed Against the Company and Nine Other Defendants in the Haifa Magistrates Court
4. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
5. Wyeth and Nycomed Announce Court Denial of Preliminary Injunction
6. Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam
7. Cristina Saralegui Joins Celebrities Including Matthew McConaughey, Courteney Cox and Mariska Hargitay to Raise Money for Breast Cancer Research
8. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
9. Rulings Send Lawsuits Against State Farm, American Family Back to Court, Hagens Berman Sobol Shapiro Announces
10. NBME Appeals Massachusetts Judges Reversal of Lower Court in Suit for Extra Break Time During Medical Licensing Exam
11. New Report Says Health Courts Bureaucracies Offer Big Financial Burdens and Loss of Patient Rights

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...resident and chief executive officer of the Alzhei...wing statement regarding the inclusion of cognitiv...ellness for Medicare beneficiaries in "The Pa...t was introduced last night: , ...ic J. Hall, president and chief executive officer ...
(Date:11/21/2009)...sk whether there is a secret to ,alcohol rehab suc... London, UK (PRWEB) November 21, 2009 -- Lin...the adult UK population drinking enough alcohol to... disease*, it is hardly a surprise that many are i...nd residential centres for help. However, for some...
(Date:11/20/2009)...swire-FirstCall/ - NUCRYST Pharmaceuticals Corp. a...ers will be held on Monday, December 21, 2009. The... two special resolutions. The first special resolu...r substantially all of the assets of NUCRYST, subs...urchase agreement dated November 10, 2009 among th...
(Date:11/20/2009)...wswire-USNewswire/ -- The United States Conference...ntial changes its health reform bill in order to k...onscience protection on abortion, protect access t...ovisions for adequate affordability. ,, The bis...us disappointment" that creates new and unacceptab...
(Date:11/20/2009)...ngressmen in Competitive Re-election Battles Could... Washington, DC (Vocus) Novembe... re-election next year in races deemed to be compe... regret voting for House Speaker Nancy Pelosi&rsqu...y International/ O’Leary Report poll. (The...
Breaking Medicine News(10 mins):Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
... at the root of higher stroke risk, study says , ...peated surges and drops in blood pressure and bloo...pnea more prone to have a stroke and die in their ... during episodes. When this happens, the organ,s b...
... and survive antibiotic attack when a protein flip...t state until treatment abates, researchers at The...report in the Jan.16 edition of Science . , "For...ichard Brennan, Ph.D., professor in M. D. Anderson...
...and operators of two Miami medical clinics, along ...eaded guilty to defrauding the Medicare program in...usion fraud scheme, Acting Assistant Attorney Gene... "Tony" Marrero, 41, Belkis Marrero, 41, and Luz B...
...m announces the availability of Trade Alerts on st...ll of the daily trading notes for free by visiting...ade Alerts include: Eli Lily & Co. (NYSE: LL...T ) and Dow Chemical Co. (NYSE: DOW ). , , Join...
...thers dying each year , , THURSDAY, Jan. 1...ne of the world,s poorest countries is 300 times m...han women living in more affluent nations, a UNICE...-fold higher chance of dying during their first mo...
...ial will examine solutions to the budgeting, forec...ted by adaptive studies. These challenges include ...nting for shifting resource allocations, timelines...inical trial software for clinical trial operation...
Other Medicine News:Health News:Sleep Apnea Seems to Wear Down the Brain 2Health News:E. coli persists against antibiotics through HipA-induced dormancy 2Health News:E. coli persists against antibiotics through HipA-induced dormancy 3Health News:Medical Clinic Executives and Worker Plead Guilty to $5.3 Medicare Fraud Scheme 2Health News:Medical Clinic Executives and Worker Plead Guilty to $5.3 Medicare Fraud Scheme 3Health News:Beacon Equity Issues Technical Trade Alerts on Headline Stocks: LLY, PCS, CAG, FRX, TGT, DOW 2Health News:Mothers, Newborns at High Risk in Developing World 2Health News:ClearTrial to Provide Guidelines for Accurately Forecasting and Budgeting Adaptive Clinical Trials at CBI Conference 2
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCa...unced results for its first quarter ended Septembe... per diluted share, on revenues of $3,263,000. Th...per diluted share, on revenues of $3,168,000 for t... the first quarter results, Biotel President and C...
(Date:11/20/2009)..., , PRINCETON, N.J., Nov. 20 /PRNewswire-... SNGX) (Soligenix or the Company), formerly known ... company, announced today that it has formed a con...nce RiVax(TM) and other rapidly acting vaccines. S...tional Institute of Allergy and Infectious Disease...
(Date:11/19/2009)..., , TAINAN, Taiwan, Nov. 19 /PRNewswi...of active pharmaceutical ingredients (APIs), annou...ent Compound Safety Certification from,SafeBridge(...inoPharm,s,competency and proficiency in the safe ...ts (APIs), and applies to specific laboratories an...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2InsiteResearch Market Momentum Continues to Accelerate 14033 1InsiteResearch Market Momentum Continues to Accelerate 14033 2InsiteResearch Market Momentum Continues to Accelerate 14033 3Implantable Defibrillators May Not Help Women With Heart Failure 57116 1Implantable Defibrillators May Not Help Women With Heart Failure 57116 2Implantable Defibrillators May Not Help Women With Heart Failure 57116 3Forest ecologist sees climate consequences 9921 1
...vention of Cervical Cancer and Other Human,Papillo...of Follow,Up in Large Phase III Clinical Studies W...d Journal of Medicine publishes the most comprehen...omavirus vaccine , LYON, France, 10th May2007 &nda...d sustained efficacy of Gardasil® in the,preve...
...Germany, May 10th, 2007 - Antisense,Pharma, a Germ...ed,therapies for malignant tumors, today announced... in high-grade glioma will be,presented at the 43r...al Oncology (ASCO), which will be held in Chicago,...en-label, randomized dose-finding Phase,IIb-trial ...
Other Medicine Technology:Gardasil Demonstrates Up to 100% Efficacy 2Gardasil Demonstrates Up to 100% Efficacy 3Gardasil Demonstrates Up to 100% Efficacy 4Gardasil Demonstrates Up to 100% Efficacy 5Gardasil Demonstrates Up to 100% Efficacy 6Gardasil Demonstrates Up to 100% Efficacy 72007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 22007 ASCO Annual Meeting: Clinical Results on Phase IIb-study with,AP 12009 in Anaplastic Astrocytoma selected for Poster Discussion 3
SMZ-1500
...1.2W Corr was designed to have the following prope...ecimens (vital sections, cell cultures, specimens ...for compensating differences in cover glass thickn...24C and 37C). The correction collar can also be u...
Achroplan objectives
Fluar objectives
Medicine Products: